Achieve Life Sciences Announces Initiation of Phase 2 ORCA-V1 Clinical Trial Evaluating Cytisinicline for Nicotine e-cigarette Cessation
29 juin 2022 08h00 HE
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, June 29, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and...
Achieve Life Sciences Announces Participation at H.C. Wainwright 1st Annual Mental Health Conference
21 juin 2022 08h00 HE
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, June 21, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global...
Achieve Life Sciences Awarded Grant from the National Institutes of Health to Conduct Phase 2 Trial of Cytisinicline in Nicotine e-cigarette Users
01 juin 2022 08h00 HE
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, June 01, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global...
Lexaria Bioscience Corp. (NASDAQ: LEXX) Stands as Global Leader in Delivery Tech Space
26 mai 2022 08h30 HE
|
Lexaria Bioscience Corp.
NEW YORK, May 26, 2022 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) announces the availability of a broadcast titled, “Nicotine Surges as Smoking Sags.” To hear...
Achieve Life Sciences Announces Participation at LD Micro Invitational Conference
26 mai 2022 08h00 HE
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, May 26, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and...
Achieve Life Sciences Announces Participation at Best Ideas Virtual Investor Conference
13 mai 2022 08h00 HE
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, May 13, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and...
Achieve Reports Financial Results for First Quarter 2022 and Provides Corporate Update
12 mai 2022 16h00 HE
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, May 12, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and...
New Randomized-Controlled Trial Finds that Quit Genius Digital Clinic is Significantly More Effective than Traditional Standard of Care for Addiction
05 mai 2022 09h00 HE
|
Quit Genius Medical, P.C.
NEW YORK, May 05, 2022 (GLOBE NEWSWIRE) -- Quit Genius, the world’s first digital clinic for treating multiple substance addictions, announced today that a new study published in Nicotine &...
Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 12, 2022
21 avr. 2022 08h00 HE
|
Achieve Life Sciences
SEATTLE and VANCOUVER, British Columbia, April 21, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development...
Insights on the Smoking Cessation & Nicotine De-Addiction Product Global Market to 2026 - Growing Awareness Regarding Use of E-Cigarettes Presents Opportunities
20 avr. 2022 06h23 HE
|
Research and Markets
Dublin, April 20, 2022 (GLOBE NEWSWIRE) -- The "Global Smoking Cessation & Nicotine De-Addiction Product Market (2021-2026) by Product, Distribution Channel, Geography, Competitive Analysis and...